Back to Report Store Home

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Published: Mar-2018
  • Report Code: GBIHC472MR
  • Report Format: pdf

Description

List of Tables

Table 1: Immunology Drugs Market, Global, Symptoms of RA, Psoriasis and IBD, 2018 17

Table 2: Immunology Drugs Market, Global, Organ-Specific Symptoms of Transplant Rejection, 2018 18

Table 3: Immunology Drugs Market, Global, Organ-Specific Symptoms of Acute GVHD, 2018 18

Table 4: Immunology Drugs Market, Global, Organ-Specific Symptoms of Chronic GVHD, 2018 19

Table 5: Immunology Drugs Market, Etiology of RA, Psoriasis, IBD and GVHD, 2018 21

Table 6: Immunology Drugs Market, 7MM, Epidemiology of Key Immunology Indications, 2018 27

Table 7: Immunology Drugs Market, Global, Approved Indications for Humira, 2018 41

Table 8: Immunology Drugs Market, Global, Approved Indications for Enbrel, 2018 44

Table 9: Immunology Drugs Market, Global, Approved Indications for Remicade, 2018 46

Table 10: Immunology Drugs Market, Global, Approved Indications for Rituxan, 2018 49

Table 11: Immunology Drugs Market, Global, Approved Indications for Stelara, 2018 51

Table 12: Immunology Drugs Market, Global, Approved Indications for Simponi, 2018 53

Table 13: Immunology Drugs Market, Global, Approved Indications for Orencia, 2018 55

Table 14: Immunology Drugs Market, Global, Approved Indications for Tysabri, 2018 57

Table 15: Immunology Drugs Market, Global, Approved Indications for Actemra, 2018 59

Table 16: Immunology Drugs Market, Global, Approved Indications for Prograf, 2018 61

Table 17: Immunology Drugs Market, Global, Approved Indications for Cimzia, 2018 62

Table 18: Immunology Drugs Market, Global, Approved Indications for Entyvio, 2018 64

Table 19: Immunology Drugs Market, Global, Approved Indications for Cosentyx, 2018 66

Table 20: Immunology Drugs Market, Global, Approved Indications for Otezla, 2018 67

Table 21: Immunology Drugs Market, Global, Approved Indications for Xeljanz, 2018 69

Table 22: Immunology Drugs Market, Global, Approved Indications for Taltz, 2018 70

Table 23: Immunology Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2016–2023 103

Table 24: Immunology Drugs Market, Global, Usage of Generics Across Key Indications, 2018 105

Table 25: Immunology Drugs Market, Global, Forecast Revenue by Company (%), 2016–2023 113

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards